First Trust Direct Indexing L.P. Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Trust Direct Indexing L.P. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,483 shares of the medical equipment provider’s stock after purchasing an additional 1,066 shares during the period. First Trust Direct Indexing L.P.’s holdings in Intuitive Surgical were worth $6,624,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Ridgewood Investments LLC purchased a new position in Intuitive Surgical during the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. Creekmur Asset Management LLC grew its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. LGT Financial Advisors LLC increased its position in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares during the period. Finally, Delos Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 53,038 shares of company stock worth $25,857,344 in the last ninety days. 0.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Royal Bank of Canada upped their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Morgan Stanley raised their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Finally, Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Trading Down 1.2 %

NASDAQ:ISRG traded down $6.26 during mid-day trading on Wednesday, hitting $510.05. The company had a trading volume of 275,992 shares, compared to its average volume of 1,458,884. Intuitive Surgical, Inc. has a 1 year low of $260.17 and a 1 year high of $523.34. The firm has a market capitalization of $181.67 billion, a price-to-earnings ratio of 83.01, a PEG ratio of 5.11 and a beta of 1.39. The business has a fifty day simple moving average of $489.22 and a 200-day simple moving average of $444.82.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.